Native-Membrane Proteoforms and Drug Selectivity
2026-08-19
Lutomski and colleagues developed a native mass-spectrometry workflow that releases membrane proteins and signaling complexes directly from retina rod disc membranes, enabling proteoform-level analysis without first disrupting the lipid bilayer. The study links lipid modifications to rhodopsin, G-protein assembly, and differential off-target binding of vardenafil and sildenafil to PDE6, providing a more physiologically grounded framework for drug-selectivity research.
SAR131675: VEGFR-3 Signaling in Fibrosis
2026-08-18
Discover how SAR131675, a selective VEGFR-3 inhibitor, can dissect VEGFC-driven lymphatic, endothelial, and hepatocyte–macrophage signaling. This article translates recent hepatic fibrosis findings into practical assay and experimental-design decisions.
WSP-5 for Real-Time H2S Imaging
2026-08-18
WSP-5, also known as Washington State Probe-5, converts hydrogen sulfide exposure into a rapid fluorescent signal for live-cell experiments. Its reaction-based turn-on design complements endpoint biochemical assays by revealing where and when H2S changes during donor testing, lipotoxicity modeling, and disease-relevant cell imaging.
Dynamic LNP Genome Editing for CNV in Mice
2026-08-17
Cao and colleagues developed dynamically covalent lipid nanoparticles that deliver Cas9 mRNA and VEGFA-targeting guide RNA for genome editing in a mouse model of choroidal neovascularization. Their chemically responsive lipidoid design improved intracellular cargo release and produced sustained VEGFA disruption and CNV reduction after a single intravitreal administration.
Acetylcholine Chloride for Gut-Brain Research
2026-08-16
Learn how Acetylcholine Chloride can serve as a controlled cholinergic stimulus in gut, vagal, neuronal, and neuromuscular assays. This practical guide translates recent Bacteroides fragilis findings into reproducible workflows, controls, and troubleshooting strategies without confusing a mechanistic probe with a microbiota therapy.
GPNMB Model Predicts Immunotherapy Response in ESCC
2026-08-15
The reference study identifies circulating soluble GPNMB as a mechanistically linked biomarker of resistance to PD-1 blockade in esophageal squamous cell carcinoma. By integrating plasma GPNMB, CAF-epithelial niche features, and clinicopathologic variables, the authors develop a multimodal framework for response and survival prediction that connects spatial tumor biology with a scalable blood-based measurement.
Angiotensin 1/2 (5-7) Research Workflow
2026-08-15
Build reproducible cardiovascular and receptor-binding assays around the H2N-Ile-His-Pro-OH peptide, with practical guidance for solubilization, dosing, controls, and readout validation. The workflow also explains how recent spike–receptor binding findings can inform exploratory cross-domain studies without overstating translational evidence.
Torin2, mTOR Signaling, and the Logic of Cell Death
2026-08-14
Torin2 is a potent, cell-permeable mTOR inhibitor that offers translational researchers a way to connect PI3K/Akt/mTOR signaling pathway inhibition with regulated cell-death biology. This article frames Torin2 as a mechanistic tool for cancer research, while using recent RNA Pol II findings to propose testable strategies for apoptosis assay design without overstating an unproven connection.
FK866 (APO866) in Reliable Cell Assays
2026-08-14
A practical, scenario-based guide to using FK866 (APO866), SKU A4381, for NAMPT inhibition, viability testing, and mechanistic interpretation. It connects concentration planning, orthogonal readouts, handling, and vendor-selection criteria to reproducible hematologic cancer research.
Mifepristone (RU486): A PR-Aware Translational Strategy
2026-08-13
Mifepristone (RU486) is more than a progesterone receptor antagonist: it is a mechanistic probe for studying receptor heterogeneity, cell-cycle control, ferroptosis, tumor biology, and reproductive function. This thought-leadership guide translates lessons from androgen receptor heterogeneity research into a practical, biomarker-aware strategy for evaluating RU486 across oncology and reproductive biology models.
Dasatinib Monohydrate in Patient-Derived Assembloids
2026-08-13
Patient-derived gastric cancer assembloids offer a more realistic setting for testing how tumor–stroma interactions reshape kinase inhibitor response. This thought-leadership article examines how Dasatinib Monohydrate, or BMS-354825, could support translational research at the intersection of imatinib-resistant BCR-ABL inhibition, stromal biology, and personalized drug screening.
MEDUSA Reveals How Drugs Trigger Cell Death
2026-08-12
Honeywell and colleagues developed MEDUSA, a simulation-assisted framework that separates drug-induced growth changes from true cell death in pooled functional-genomic screens. Applied to DNA damage, the method showed that p53 loss redirects cells from apoptosis toward a nonapoptotic death state that depends on high respiration, clarifying how genetic context can alter drug response.
SAR131675: Selective VEGFR-3 Inhibitor
2026-08-12
SAR131675 is a selective ATP-competitive VEGFR-3 inhibitor with nanomolar biochemical and cellular activity. Its preclinical profile supports anti-lymphangiogenic research, endothelial migration studies, and tumor growth inhibition, but development was discontinued because of adverse metabolic effects.
HyperFluor 488 Goat Anti-Mouse IgG for PRRSV Assays
2026-08-11
Learn how to use a HyperFluor 488 Goat Anti-Mouse IgG secondary reagent to strengthen PRRSV immunofluorescence, flow cytometry, and western blot workflows. The guide translates a recent PRRSV-1 isolation study into practical assay controls, optimization steps, and troubleshooting decisions.
Simvastatin (Zocor) in Stress-Linked Cell Assays
2026-08-10
Explore how Simvastatin (Zocor) can support cholesterol, hepatic cancer, and stress-response research through a time-resolved assay strategy. This guide connects HMG-CoA reductase biology with lessons from STMN2 translation and stress-granule research while defining practical controls and limitations.
458 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page